Bio-Strategy Revenue and Competitors
Estimated Revenue & Valuation
- Bio-Strategy's estimated annual revenue is currently $10.5M per year.
- Bio-Strategy's estimated revenue per employee is $102,000
Employee Data
- Bio-Strategy has 103 Employees.
- Bio-Strategy grew their employee count by 0% last year.
Bio-Strategy's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Marketing, ANZ | Reveal Email/Phone |
3 | Purchasing Officer | Reveal Email/Phone |
4 | Customer Service Officer | Reveal Email/Phone |
5 | Executive Director | Reveal Email/Phone |
6 | Senior Product Manager | Reveal Email/Phone |
7 | Product Manager | Reveal Email/Phone |
8 | Product Manager (Oceania) | Reveal Email/Phone |
9 | Service Manager | Reveal Email/Phone |
10 | Product Manager | Reveal Email/Phone |
Bio-Strategy Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $18.5M | 165 | 25% | N/A | N/A |
#2 | $8.8M | 86 | 4% | N/A | N/A |
#3 | $11.2M | 110 | -2% | N/A | N/A |
#4 | $10.5M | 103 | 0% | N/A | N/A |
#5 | $13.7M | 134 | -6% | N/A | N/A |
#6 | $8.3M | 81 | 3% | N/A | N/A |
#7 | $27.2M | 242 | 5% | N/A | N/A |
#8 | $64M | 502 | 6% | N/A | N/A |
#9 | $110.2M | 772 | N/A | N/A | N/A |
#10 | $57.9M | 454 | 8% | N/A | N/A |
What Is Bio-Strategy?
Delivering technology. Supplying specialist scientific instrumentation, equipment and consumables to the scientific and diagnostic markets in Australia, New Zealand and the South Pacific. We offer sales, applications support and technical service for all our products. Our key agencies include One Lambda Inc., Hamilton Company, Hamilton Robotics, Molecular Devices, Qiagen (NZ Only), Leica (NZ only), Priorclave, UVP, Labogene, and Kaltis.
keywords:N/AN/A
Total Funding
103
Number of Employees
$10.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Bio-Strategy News
"We're embarking on a major investment strategy in the US to become ... of that firm's future diagnostics strategies with Bio-Rad executives...
Strategy and resource alignment support funding of operations ... SGT-001 is based on pioneering research in dystrophin biology by Dr.
BridgeBio strategy head departs amid company's second round of layoffs this year ... BridgeBio's chief strategy officer is headed for the exits as...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 104 | 22% | N/A |
#2 | $18.9M | 105 | 2% | N/A |
#3 | $30.7M | 106 | 5% | N/A |
#4 | $17.4M | 109 | 1% | N/A |
#5 | $15.8M | 109 | -5% | N/A |